Inactive Instrument

News Roche Holding AG Xetra

Equities

Xbrane Biopharma, Stada Sign US Licensing Deal for Lucentis Biosimilar	05-10	MT
Enable Injections, Inc. Announces Collaboration with Roche to Develop and Commercialize Combination of the enFuse Technology with Specific Roche Development Programs	05-07	CI
ROCHE HOLDINGS AG : UBS reiterates its Neutral rating	05-06	ZD
Swiss Equities Close in Red Amid Inflation Spotlight	04-29	MT
Roche Holding AG: slimming down	04-29
Roche: positive opinion from CHMP for subcutaneous Ocrevus	04-29	CF
European Medicines Agency Committee Backs Roche's Subcutaneous Injection for Multiple Sclerosis	04-29	MT
Roche: positive CHMP opinion for Alecensa	04-26	CF
Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU	04-26	MT
The specter of stagflation rears its ugly head again	04-25
ROCHE : Barclays lowers target price	04-25	CF
Scholz pledges further support for the pharmaceutical industry	04-25	DP
ROCHE HOLDINGS AG : UBS remains Neutral	04-25	ZD
ROCHE HOLDINGS AG : Barclays sticks Neutral	04-25	ZD
Scholz promises support for pharma sector in Germany as Merck invests	04-25	RE
Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5%	04-25	MT
Health Care Down Amid Mixed Earnings -- Health Care Roundup	04-24	DJ
ROCHE HOLDINGS AG : DZ Bank reiterates its Buy rating	04-24	ZD
Roche’s Downbeat Q1 Sales Drag Swiss Market Index to Red	04-24	MT
ROCHE HOLDING : In line quarterly results won’t cut it for Roche	04-24

No results for this search

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am